iShares Neuroscience and Healthcare ETF (IBRN) price, chart and fund profile
Price chart
Fund profile
IBRN tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.
- Issuer
- BlackRock Fund Advisors
- Industry
- Healthcare
- Inception
- Aug 24, 2022
- Expense ratio
- 0.47%
- Net asset value
- $39.17
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- www.ishares.com↗
Frequently asked questions
What is iShares Neuroscience and Healthcare ETF (IBRN)?
IBRN tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.
What is IBRN's expense ratio?
iShares Neuroscience and Healthcare ETF charges an annual expense ratio of 0.47%. The fund is issued by BlackRock Fund Advisors.
How large is IBRN?
iShares Neuroscience and Healthcare ETF manages $7.8M in assets and has traded since Aug 24, 2022.
How do I buy shares of iShares Neuroscience and Healthcare ETF (IBRN)?
IBRN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.